Haoting Zhan

Haoting Zhan

Auto-generated profile, based on publicly available information

Haoting Zhan

Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
HZHaoting Zhan
Haoting Zhan
HCHaizhen Chen
Haizhen Chen
CLChenxi Liu
Chenxi Liu
LCLinlin Cheng
Linlin Cheng
SYSongxin Yan
Songxin Yan
YLYongzhe Li
Yongzhe Li
The prognostic role of hypercoagulability in COVID-19 patients is ambiguous. D-dimer, may be regarded as a global marker of hemostasis activation in COVID-19. Our study was to assess the predictive value of D-dimer for the severity, mortality and incidence of venous thromboembolism (VTE) events in COVID-19 patients. PubMed, EMBASE, Cochrane Library and Web of Science databases were searched. The pooled diagnostic value (95% confidence interval [CI]) of D-dimer was evaluated with a bivariate mixed-effects binary regression modeling framework. Sensitivity analysis and meta regression were used to determine heterogeneity and test robustness. A Spearman rank correlation tested threshold effect caused by different cut offs and units in D-dimer reports. The pooled sensitivity of the prognostic performance of D-dimer for the severity, mortality and VTE in COVID-19 were 77% (95% CI: 73%-80%), 75% (95% CI: 65%-82%) and 90% (95% CI: 90%-90%) respectively, and the specificity were 71% (95% CI: 64%-77%), 83% (95% CI: 77%-87%) and 60% (95% CI: 60%-60%). D-dimer can predict severe and fatal cases of COVID-19 with moderate accuracy. It also shows high sensitivity but relatively low specificity for detecting COVID-19-related VTE events, indicating that it can be used to screen for patients with VTE.

3 January 2023 in Journal of Medical Virology
Verified
Journal Article
Closed access
HZHaoting Zhan
Haoting Zhan
HGHuixia Gao
Huixia Gao
YLYongmei Liu
Yongmei Liu
XZXihong Zhang
Xihong Zhang
HLHaolong Li
Haolong Li
YLYongzhe Li
Yongzhe Li

12 October 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
XLXiaomeng Li
Xiaomeng Li
YLYongmei Liu
Yongmei Liu
LCLinlin Cheng
Linlin Cheng
YHYuan Huang
Yuan Huang
SYSongxin Yan
Songxin Yan
YLYongzhe Li
Yongzhe Li
Background: Anti‐melanoma differentiation‐associated gene 5 (MDA5)‐positive dermatomyositis (MDA5+DM) is significantly associated with interstitial lung disease (ILD), especially rapidly progressive ILD (RPILD) due to poor prognosis, resulting in high mortality rates. However, the pathogenic mechanism of MDA5+DM‐RPILD is unclear. Although some MDA5+DM patients have a chronic course of ILD, many do not develop RPILD. Therefore, the related biomarkers for the early diagnosis, disease activity monitoring, and prediction of the outcome of RPILD in MDA5+DM patients should be identified. Blood‐based biomarkers are minimally invasive and can be easily detected.Methods: Recent relative studies related to blood biomarkers in PubMed were reviewed.Results: An increasing number of studies have demonstrated that dysregulated expression of blood biomarkers related to ILD such as ferritin, Krebs von den Lungen‐6 (KL‐6), surfactant protein‐D (SP‐D), and cytokines, and some tumor markers in MDA5+DM may provide information in disease presence, activity, treatment response, and prognosis. These studies have highlighted the great potentials of blood biomarker values for MDA5+DM‐ILD and MDA5+DM‐RPILD. This review provides an overview of recent studies related to blood biomarkers, besides highlighted protein biomarkers, including antibody (anti‐MDA5 IgG subclasses and anti‐Ro52 antibody), genetic (exosomal microRNAs and neutrophil extracellular traps related to cell‐free DNA), and immune cellular biomarkers in MDA5+DM, MDA5+DM‐ILD, and MDA5+DM‐RPILD patients, hopefully elucidating the pathogenesis of MDA5+DM‐ILD and providing information on the early diagnosis, disease activity monitoring, and prediction of the outcome of the ILD, especially RPILD.Conclusions: Therefore, this review may provide insight to guide treatment decisions for MDA5+DM‐RPILD patients and improve outcomes.

7 January 2025 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
HZHaoting Zhan
Haoting Zhan
LCLinlin Cheng
Linlin Cheng
YLYongzhe Li
Yongzhe Li
Neuro-Behçet’s disease (NBD) is a more severe but rare symptom of Behçet’s disease, which is mainly divided into parenchymal NBD (p-NBD) involving brain stem, spinal cord, and cerebral cortex. Non-p-NBD manifests as intracranial aneurysm, cerebral venous thrombosis, peripheral nervous system injuries, and mixed parenchymal and non-parenchymal disease. p-NBD is pathologically characterized by perivasculitis presenting with cerebrospinal fluid (CSF) pleocytosis, elevated total protein, and central nervous system (CNS) infiltration of macrophages and neutrophils, which are subdivided into acute and chronic progressive stages according to relapsing–remitting courses and responses to steroids. The diagnosis of NBD depends heavily on clinical features and magnetic resonance imaging (MRI) findings. The lack of laboratory biomarkers has hindered standard diagnostics. CSF interleukin (IL)-6 is the most investigated dimension of NBD and correlates with NBD activity, therapeutic responses, and prognosis. Further investigations have focused on inflammatory biomarkers that reflect the activation of innate and adaptive immune responses. Higher levels of CSF migration inhibitory factor and immunosuppressive acidic protein indicated the activation of macrophages in the CNS; increased IL-17, IL-10, T-bet/GATA-3, and retinoic acid related orphan receptor (ROR)-γt/Foxp3 ratios, marking the disrupted scale of the Th1/Th2 and Th17/Treg axis; and elevated B-cell activating factor of the TNF family (BAFF) and IgA/IgM intrathecal synthesis, suggesting that B cells play a dominant role in NBD. CNS destruction and degeneration as a consequence of neuroinflammatory cascades were confirmed by elevated CSF levels of NFL, β2MG, and MBP. Autoantibodies, including anti-STIP-1, anti-Mtch1, anti-B-Crystallin, and anti-m-Hsp65, provide substantial evidence for autoimmune essence and underlying microbiological infections in NBD immunopathogenesis. We summarized opinions on the clinical diagnosis, biomarkers, and pathological findings of NBD.

21 June 2023 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
HZHaoting Zhan
Haoting Zhan
LCLinlin Cheng
Linlin Cheng
HLHaolong Li
Haolong Li
YLYongmei Liu
Yongmei Liu
YHYuan Huang
Yuan Huang
YLYongzhe Li
Yongzhe Li

22 January 2023 in Journal of Infection
Verified
Journal Article
Closed access
HZHaoting Zhan
Haoting Zhan
LYLi Yang
Li Yang
YLYongmei Liu
Yongmei Liu
HLHaolong Li
Haolong Li
XLXiaomeng Li
Xiaomeng Li
YLYongzhe Li
Yongzhe Li